Ultragenyx to Participate at Investor Conferences in March
2024年2月28日 - 6:30AM
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a
biopharmaceutical company focused on the development and
commercialization of novel therapies for serious rare and ultrarare
genetic diseases, today announced that management will be
participating in three upcoming investor conferences.
44th Annual Cowen
Healthcare Conference (Boston, MA)
- Monday, March 4, 2024, Eric Crombez,
M.D., Chief Medical Officer, will participate in a fireside chat
and host 1x1 meetings.
Leerink Partners Global Biopharma Conference (Miami,
FL)
- Tuesday, March 12, 2024, Emil
Kakkis, M.D., Ph.D., CEO and President and Howard Horn, Chief
Financial Officer, will participate in a fireside chat and host 1x1
meetings.
Barclays 26th Annual
Global Healthcare Conference (Miami, FL)
- Wednesday, March 13, 2024, Emil
Kakkis and Howard Horn will participate in a fireside chat and host
1x1 meetings.
The live and archived webcast of the fireside chat will be
accessible from the company’s website at
https://ir.ultragenyx.com/events-presentations.
About Ultragenyx
Ultragenyx is a biopharmaceutical company committed to bringing
novel products to patients for the treatment of serious rare and
ultrarare genetic diseases. The company has built a diverse
portfolio of approved therapies and product candidates aimed at
addressing diseases with high unmet medical need and clear biology
for treatment, for which there are typically no approved therapies
treating the underlying disease.
The company is led by a management team experienced in the
development and commercialization of rare disease therapeutics.
Ultragenyx’s strategy is predicated upon time- and cost-efficient
drug development, with the goal of delivering safe and effective
therapies to patients with the utmost urgency.
For more information on Ultragenyx, please visit the company's
website at: www.ultragenyx.com.
Contacts – UltragenyxInvestorsir@ultragenyx.com
Mediamedia@ultragenyx.com
Ultragenyx Pharmaceutical (NASDAQ:RARE)
過去 株価チャート
から 5 2024 まで 6 2024
Ultragenyx Pharmaceutical (NASDAQ:RARE)
過去 株価チャート
から 6 2023 まで 6 2024